The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms
- PMID: 9002545
- DOI: 10.1016/s0272-6386(97)90023-8
The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms
Abstract
Several systemic or intrarenal networks of cytokines and growth factors can be modulated by the diabetic state. We summarize the status of the renin-angiotensin system in diabetes mellitus and review the evidence of its involvement in the pathogenesis of diabetic nephropathy. Particular emphasis is placed on the nonhemodynamic properties of this vasoactive agent as both a renal growth factor and a profibrogenic peptide. Antagonizing the effects of angiotensin II with converting enzyme inhibitors is an established protective strategy in the management of diabetic nephropathy even in the absence of systemic hypertension. This and other indirect evidence from experimental animal studies suggest that the intrarenal concentration of angiotensin II may be increased as a result of increased synthesis and despite enhanced breakdown, that this peptide participates in the progression of diabetic nephropathy. However, down-regulation of angiotensin type 1 (AT1)-receptors is one of the abnormalities of both tubules and glomeruli in diabetic renal disease. A heightened bioactivation of the intrarenal angiotensin II system is therefore likely but not certain. Studies in cultured proximal tubular and glomerular mesangial cells have disclosed striking similarities between the effects of high glucose-containing medium and of treatment with angiotensin II on the growth properties and the induction of cytokines in these cells. There may also exist additive effects of angiotensin II and high glucose on signal-transduction pathways, such as activation of protein kinase C, although the contractile response to angiotensin II may be blunted by high glucose in mesangial cells. An important downstream mediator of the effects of both angiotensin II and high glucose is the activation of transforming growth factor-beta that can mediate at least some of the hypertrophic and profibrotic effects of either angiotensin II or high glucose in the diabetic kidney.
Similar articles
-
Angiotensin II and its receptors in the diabetic kidney.Am J Kidney Dis. 2000 Sep;36(3):449-67. doi: 10.1053/ajkd.2000.16192. Am J Kidney Dis. 2000. PMID: 10977776 Review.
-
Role of angiotensin II in diabetic nephropathy.Kidney Int Suppl. 2000 Sep;77:S93-8. doi: 10.1046/j.1523-1755.2000.07715.x. Kidney Int Suppl. 2000. PMID: 10997697 Review.
-
Activation of a local renin angiotensin system in podocytes by glucose.Am J Physiol Renal Physiol. 2008 Apr;294(4):F830-9. doi: 10.1152/ajprenal.00266.2007. Epub 2008 Jan 23. Am J Physiol Renal Physiol. 2008. PMID: 18216149
-
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].Presse Med. 2002 Nov 9;31(36):1714-20. Presse Med. 2002. PMID: 12467154 Review. French.
-
Role of angiotensin II in diabetic nephropathy.Semin Nephrol. 1997 Sep;17(5):441-7. Semin Nephrol. 1997. PMID: 9316212 Review.
Cited by
-
Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC).J Biol Chem. 2013 Aug 23;288(34):24834-47. doi: 10.1074/jbc.M113.485326. Epub 2013 Jul 11. J Biol Chem. 2013. PMID: 23846697 Free PMC article.
-
The renin-angiotensin system and diabetes: an update.Vasc Health Risk Manag. 2008;4(4):787-803. Vasc Health Risk Manag. 2008. PMID: 19065996 Free PMC article. Review.
-
Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology.Antioxid Redox Signal. 2016 Nov 1;25(13):732-748. doi: 10.1089/ars.2016.6661. Epub 2016 Mar 18. Antioxid Redox Signal. 2016. PMID: 26937558 Free PMC article. Review.
-
Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?PLoS One. 2013;8(2):e54442. doi: 10.1371/journal.pone.0054442. Epub 2013 Feb 4. PLoS One. 2013. PMID: 23390498 Free PMC article.
-
Hyperglycemia activates the renin-angiotensin system and induces epithelial-mesenchymal transition in streptozotocin-induced diabetic kidneys.J Renin Angiotensin Aldosterone Syst. 2018 Jul-Sep;19(3):1470320318803009. doi: 10.1177/1470320318803009. J Renin Angiotensin Aldosterone Syst. 2018. PMID: 30264671 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials